Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Raul Zamora-Ros, L'Hospitalet de Llobregat, Spanien
  • Muath A Alghamdi, College of Medicine, Al Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia., L'Hospitalet de Llobregat, Saudi-Arabien
  • Valerie Cayssials, L'Hospitalet de Llobregat, Spanien
  • Silvia Franceschi, Epidemiology Unit, Aviano Cancer Center, Milan, Italy., Italien
  • Martin Almquist, Malmö University Hospital, Malmö, Sverige
  • Joakim Hennings, Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden., Sverige
  • Maria Sandström, Umeå University, Sverige
  • Konstantinos K Tsilidis, School of Public Health, Imperial College London, London, United Kingdom., University of Ioannina School of Medicine, Storbritannien
  • Elisabete Weiderpass, Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland, Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway, Cancer Registry of Norway Institute of Population-Based Cancer Research, Karolinska Institutet, Finland
  • Marie-Christine Boutron-Ruault, Institut Gustave Roussy, Villejuif, France., Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France., Frankrig
  • Bodil Hammer Bech
  • Kim Overvad
  • Anne Tjønneland, Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark., Danmark
  • Kristina E N Petersen, Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark., Danmark
  • Francesca Romana Mancini, Institut Gustave Roussy, Villejuif, France., Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France., Frankrig
  • Yahya Mahamat-Saleh, Institut Gustave Roussy, Villejuif, France., Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France., Frankrig
  • Fabrice Bonnet, CHU Rennes, EA 1254 Microbiologie Risques infectieux, Université de Rennes 1, Rennes, France., Université Paris-Saclay, Univ. Paris-Sud, UVSQ, Inserm, CESP, Generations and health., Institut Gustave Roussy, Villejuif, France.
  • ,
  • Tilman Kühn, Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany., Tyskland
  • Renée T Fortner, Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany., Tyskland
  • Heiner Boeing, Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany., Tyskland
  • Antonia Trichopoulou, WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology, and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Hellenic Health Foundation, Athens, Greece, Grækenland
  • Christina Bamia, WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology, and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Hellenic Health Foundation, Athens, Greece, Grækenland
  • Georgia Martimianaki, Hellenic Health Foundation, Athens, Greece., Grækenland
  • Giovanna Masala, Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, 50141 Florence, Italy. d.palli@ispo.toscana.it., Italien
  • Sara Grioni, Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Italien
  • Salvatore Panico, Department of Clinical and Experimental Medicine, Federico II University, 80131 Naples, Italy., Italien
  • Rosario Tumino, Cancer Registry and Histopathology Unit, 'Civic-M.P. Arezzo' Hospital, 97100 ASP Ragusa, Italy., Italien
  • Francesca Fasanelli, Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy., Italien
  • Guri Skeie, Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037 Tromsø, Norway., Norge
  • Tonje Braaten, Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037 Tromsø, Norway., Norge
  • Cristina Lasheras, Department of Functional Biology, Faculty of Medicine, University of Oviedo, CP 33006 Oviedo, Asturias, Spain., Spanien
  • Elena Salamanca-Fernández, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs. GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Spanien
  • Pilar Amiano, Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia, Spain., CIBER de Epidemiología y Salud Pública (CIBERESP), Spain., Spanien
  • Maria-Dolores Chirlaque, Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain., CIBER de Epidemiología y Salud Pública (CIBERESP), Spain., Spanien
  • Aurelio Barricarte, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., CIBER de Epidemiología y Salud Pública (CIBERESP), Spain., Public Health Institute of Navarra, Spanien
  • Jonas Manjer, Department of Surgery, Lund University, Skåne University Hospital, Malmö, Sweden, Sverige
  • Peter Wallström, Nutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden., Sverige
  • H Bas Bueno-de-Mesquita, Julius Centre University of Malaya, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia;, Imperial College London, National Institute for Public Health and the Environment (RIVM), University Medical Centre Utrecht, Malaysia
  • Petra H Peeters, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Holland
  • Kay-Thee Khaw, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Storbritannien
  • Nicholas J Wareham, MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom., Storbritannien
  • Julie A Schmidt, Cancer Epidemiology Unit, University of Oxford, Oxford, UK., Storbritannien
  • Dagfinn Aune, School of Public Health, Imperial College London, London, United Kingdom., Storbritannien
  • Graham Byrnes, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Frankrig
  • Augustin Scalbert, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Frankrig
  • Antonio Agudo, Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain., Spanien
  • Sabina Rinaldi, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Frankrig

PURPOSE: Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study.

METHODS: The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires.

RESULTS: During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HRcalibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HRcalibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HRcalibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HRcalibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases.

CONCLUSIONS: In this large prospective study, coffee and tea consumptions were not associated with TC risk.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Nutrition
Vol/bind58
Nummer8
Sider (fra-til)3303-3312
Antal sider10
ISSN1436-6207
DOI
StatusUdgivet - dec. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 138549079